Genmab — Marts 2011
-
det står i årsrapporten som jeg har fortrængt allerede
-
GSK har gjort ALT for arzerra
-
så det skal altså ikke gøre en nervøs
-
gsk er ligeglad med overskud
-
de skal kunne regne stoffet hjem....
-
men hvis opkøbstankerne skal være andet end bullshit så skal de da komme igang nu
-
jo de får da eksekveret godt på strategien
-
markedet er faldet sammen for biotek aktier
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind